dopexamine has been researched along with sk&f-38393 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stanford, GG | 1 |
Hegde, SS; Lokhandwala, MF; Vyas, SJ | 1 |
Jacinto, SM; Jandhyala, BS | 1 |
1 review(s) available for dopexamine and sk&f-38393
Article | Year |
---|---|
Use of inotropic agents in critical illness.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Cardiac Output; Cardiotonic Agents; Catecholamines; Critical Care; Dopamine; Fenoldopam; Humans; Imidazoles; Ketanserin; Oxygen; Phosphodiesterase Inhibitors; Quinolines; Vasodilator Agents | 1991 |
2 other study(ies) available for dopexamine and sk&f-38393
Article | Year |
---|---|
Renal dopamine and tubular DA-1 receptors in the regulation of sodium excretion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Atrial Natriuretic Factor; Dopamine; Dopamine Agents; Fenoldopam; Kidney; Kidney Tubules; Male; Natriuresis; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1990 |
Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic beta-Agonists; Animals; Blood Pressure; Dobutamine; Dopamine; Fenoldopam; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine; Superoxide Dismutase; Xanthine; Xanthine Oxidase; Xanthines | 1994 |